Age: 78.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Asthenia, Blood glucose fluctuation, Body height, Enuresis, Fatigue
Clinical narrative: She was unconscious with pain; She slept right through, hurt all over; was tired; weak; peed in bed; cannot walk long distances; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A 78-year-old female patient received BNT162b2 (BNT162B2), on 04Jan2022 as dose 4 (booster), single (Lot number: FJ8762) at the age of 78 years for covid-19 immunisation. The patient's relevant medical history included: "hair loss" (unspecified if ongoing); "COVID-19" (unspecified if ongoing), notes: Caller tested positive for the Virus. On 11Aug2022 she was either exposed or diagnosed with COVID.; "She is partially in a wheelchair" (ongoing); "Rescue Inhaler" (unspecified if ongoing); "blood sugar level" (unspecified if ongoing); "head injury" (unspecified if ongoing), notes: She is also post head injury. Concomitant medication(s) included: ALLEGRA [FEXOFENADINE HYDROCHLORIDE]; ALBUTEROL [SALBUTAMOL SULFATE] taken for inhalation therapy; ATORVASTATIN CALCIUM; BIOTIN taken for alopecia; CANNABIDIOL; CINNAMON [CINNAMOMUM CASSIA] taken for blood glucose abnormal; CRANBERRY; EYE DROPS [NAPHAZOLINE HYDROCHLORIDE]; FISH OIL; KERATIN taken for alopecia; METAMUCIL [PLANTAGO OVATA]; OSTEO-BI-FLEX; PREDNISONE; QVAR; SELENIUM [SELENIUM SULFIDE]; SINGULAIR; TURMERIC CURCUMIN [CURCUMA LONGA]; TRULICITY; VITAMIN B12 [VITAMIN B12 NOS] taken for injection; VITAMIN D3; VITAMIN E [TOCOPHEROL]; ZINC. Vaccination history included: coviD-19 vaccine (1st dose Pfizer COVID-19 Vaccine: , Date Received: 18Jan2021, Lot number: either EL or LL 3249), administration date: 18Jan2021, when the patient was 77-year-old, for COVID-19 immunization; coviD-19 vaccine (2nd dose Pfizer COVID-19 Vaccine:, Date Received: 10Feb2021, Lot number: EL3247), administration date: 10Feb2021, when the patient was 77-year-old, for COVID-19 Immunization; coviD-19 vaccine (3rd dose Pfizer COVID-19 Vaccine:, Lot number: FC3181, Date Received: 12Sep2021), administration date: 12Sep2021, when the patient was 77-year-old, for covid-19 immunization. The following information was reported: LOSS OF CONSCIOUSNESS (medically significant), outcome "recovering", described as "She was unconscious with pain"; PAIN (non-serious), outcome "recovering", described as "She slept right through, hurt all over"; FATIGUE (non-serious), outcome "recovering", described as "was tired"; ASTHENIA (non-serious), outcome "recovering", described as "weak"; ENURESIS (non-serious), outcome "recovering", described as "peed in bed"; MOVEMENT DISORDER (non-serious), outcome "recovering", described as "cannot walk long distances". The patient underwent the following laboratory tests and procedures: Blood glucose fluctuation: down; Body height: 5 feet 3.5-4 inches; Nasopharyngeal swab: Positive, notes: She tested positive for swabs for COVID-19; tested positive twice; Positive, notes: She tested positive for swabs for COVID-19; tested positive twice; Pulmonary function test: normal lung capacity is 75; for 5 years she has been 35; now 67; Weight (180-190): 180-190 lbs, notes: 180-190 pounds as she is just getting off steroids that she has been on for 2 years. Therapeutic measures were taken as a result of loss of consciousness, pain, fatigue, asthenia, enuresis, movement disorder.